NeuroSense Therapeutics Ltd. Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NRSNW and buy or sell other stocks, ETFs, and their options commission-free!

About NRSNW

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS). 

CEO
Alon Ben-Noon, MBA
CEOAlon Ben-Noon, MBA
Employees
—
Employees—
Headquarters
Herzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded
2017
Founded2017
Employees
—
Employees—

NRSNW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
90.30
Average volume90.30
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$1.00
52 Week high$1.00
52 Week low
$0.16
52 Week low$0.16

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.